Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chunji Chen

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
International Journal of Surgery (London, England)|September 24, 2025
Adjuvant immunotherapy for esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy: a multicenter real-world studyChunji Chen, Ziqiang Tian, Jiangbo Lin, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 10, 2025
Lymph node dissection in neoadjuvant chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma: A multicenter real-world studyChunji Chen, Huilai Lv, Jinbo Zhao, et al.
JAMA Surgery|March 19, 2025
Neoadjuvant Chemoradiotherapy vs Chemoimmunotherapy for Esophageal Squamous Cell CarcinomaXufeng Guo, Chunji Chen, Jinbo Zhao, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 25, 2026
Association of immune-related adverse events with survival outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy: a national multicenter retrospective cohort study in ChinaChunji Chen, Chang Yuan, Zhichao Liu, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 28, 2026
Pathologic complete response after neoadjuvant immunochemotherapy: persistent recurrence risk highlights the need for stratified managementChang Yuan, Chunji Chen, Zhichao Liu, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
International Journal of Surgery (London, England)|September 24, 2025
Adjuvant immunotherapy for esophageal squamous cell carcinoma after neoadjuvant chemoimmunotherapy: a multicenter real-world studyChunji Chen, Ziqiang Tian, Jiangbo Lin, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 10, 2025
Lymph node dissection in neoadjuvant chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma: A multicenter real-world studyChunji Chen, Huilai Lv, Jinbo Zhao, et al.
JAMA Surgery|March 19, 2025
Neoadjuvant Chemoradiotherapy vs Chemoimmunotherapy for Esophageal Squamous Cell CarcinomaXufeng Guo, Chunji Chen, Jinbo Zhao, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|January 25, 2026
Association of immune-related adverse events with survival outcomes in esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy: a national multicenter retrospective cohort study in ChinaChunji Chen, Chang Yuan, Zhichao Liu, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 28, 2026
Pathologic complete response after neoadjuvant immunochemotherapy: persistent recurrence risk highlights the need for stratified managementChang Yuan, Chunji Chen, Zhichao Liu, et al.
Pageof 5